1. Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom;
2. Children’s Cancer Group, Institute of Cancer, Faculty of Medical & Human Sciences, The University of Manchester, Manchester, United Kingdom;
3. Royal Manchester Children’s Hospital, Central Manchester University Hospitals Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom;
4. Children’s Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia;
5. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands;
6. Dutch Childhood Oncology Group, The Hague, The Netherlands;
7. Department of Paediatric Oncology and Haematology, Erasmus MC–Sophia Children’s Hospital, University Medical Centre, Rotterdam, The Netherlands;
8. Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom;
9. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;
10. Department of Haematology-Oncology, SA Pathology at Women’s and Children’s Hospital and University of Adelaide, Adelaide, Australia; and
11. Tata Translational Cancer Research Centre, Tata Medical Center, New Town, Kolkata, India